search button
Open Access

Morphological and functional alterations of the prostate tissue during clinical progression in hormonally‑naïve, hormonally‑treated and castration‑resistant patients with metastatic prostate cancer

  • Authors:
    • Michal Korček
    • Monika Sekerešová
    • Alexander V. Makarevich
    • Helena Gavurová
    • Lucia Olexíková
    • Juraj Pivko
    • Lenka Barreto

  • View Affiliations

  • Published online on: September 8, 2020     https://doi.org/10.3892/ol.2020.12064
  • Article Number: 201

  • Copyright: © Korček et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Since commony used tools in oncological practice for the diagnosis of castration‑resistent prostatic acinar adenocarcinoma are based on clinical criteria, such as castrate testosterone level, continuous rise in serum prostate‑specific antigen, progression of preexisting disease or appearance of new metastases, it is important to identify reliable histopathological markers for the identification of this disease. Therefore, the aim of the present study was to determine the association between results from histological analysis, ultrastructural analysis and apoptosis in the prostate of patients with metastatic acinar prostatic adenocarcinoma (mPC). Patients were treated with androgen deprivation therapy (ADT), abiraterone acetate (Abi) therapy or received no treatment. Prostate tissue samples were divided into four groups as follows: i) Group 1, tissues from patients with benign prostatic hyperplasia (adenocarcinoma negative); ii) group 2, tissues from patients with metastatic hormone naïve prostate cancer; iii) group 3, tissues from patients with mPC treated with ADT; and iv) group 4, tissues from patients with metastatic castration‑resistant prostate cancer treated with ADT and Abi. Immunohistochemical, terminal deoxynucleotidyl‑transferase‑mediated dUTP nick end labelling (TUNEL) and ultrastructural assays using light, fluorescence and transmission electron microscopy, respectively, were used to analyze prostate tissue samples. The results demonstrated that ADT and Abi therapy caused histological and ultrastructural changes in prostate tissues. In groups 3 and 4, benign and malignant tissues were affected by the hormonal therapy. Histologically, the malignant epithelium after ADT therapy in groups 3 and 4 presented with a loss of glandular architecture, nuclear and nucleolar shrinkage, chromatin condensation and cytoplasmic clearing. At the ultrastructural level, compact hypertrophic and hyperchromatic nuclei with numerous invaginations were observed in groups 2, 3 and 4. In addition, the incidence of abnormal mitochondria in malignant cells of these groups was high. Group 4 was characterized by the presence of malignant mesenchyme‑like cells in the prostatic stroma, arranged in small groups surrounded by collagen fibrils. Furthermore, the cytoplasm of these cells contained filaments. A decrease in the number of apoptotic cells using TUNEL assays in the examined samples was observed with increasing disease progression. The findings from the present study suggest that the duration of treatment with ADT and progression of the disease were associated with apoptosis dysregulation.
View Figures
View References

Related Articles

Journal Cover

November-2020
Volume 20 Issue 5

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 2.5
  • Ranked Oncology
    (total number of cites)
  • CiteScore: 5.7
  • CiteScore Rank: Q2: #139/404 Oncology
  • Source Normalized Impact per Paper (SNIP): 0.574
  • SCImago Journal Rank (SJR): 0.644
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
Korček M, Sekerešová M, Makarevich AV, Gavurová H, Olexíková L, Pivko J and Barreto L: Morphological and functional alterations of the prostate tissue during clinical progression in hormonally‑naïve, hormonally‑treated and castration‑resistant patients with metastatic prostate cancer. Oncol Lett 20: 201, 2020.
APA
Korček, M., Sekerešová, M., Makarevich, A.V., Gavurová, H., Olexíková, L., Pivko, J., & Barreto, L. (2020). Morphological and functional alterations of the prostate tissue during clinical progression in hormonally‑naïve, hormonally‑treated and castration‑resistant patients with metastatic prostate cancer. Oncology Letters, 20, 201. https://doi.org/10.3892/ol.2020.12064
MLA
Korček, M., Sekerešová, M., Makarevich, A. V., Gavurová, H., Olexíková, L., Pivko, J., Barreto, L."Morphological and functional alterations of the prostate tissue during clinical progression in hormonally‑naïve, hormonally‑treated and castration‑resistant patients with metastatic prostate cancer". Oncology Letters 20.5 (2020): 201.
Chicago
Korček, M., Sekerešová, M., Makarevich, A. V., Gavurová, H., Olexíková, L., Pivko, J., Barreto, L."Morphological and functional alterations of the prostate tissue during clinical progression in hormonally‑naïve, hormonally‑treated and castration‑resistant patients with metastatic prostate cancer". Oncology Letters 20, no. 5 (2020): 201. https://doi.org/10.3892/ol.2020.12064